J. Safra Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

J. Safra Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-310,817	Closed	-$25.2M	–	402
2025 Q1	$25.2M	Buy	310,817 +18,315	+6%	+$1.64M	2.05%	15
2024 Q4	$26.3M	Buy	292,502 +240,415	+462%	+$23.3M	2.14%	14
2024 Q3	$5.13M	Buy	52,087 +48,513	+1,357%	+$4.77M	0.49%	22
2024 Q2	$331K	Hold	3,574	–	–	0.03%	46
2024 Q1	$339K	Hold	3,574	–	–	0.04%	32
2023 Q4	$319K	Hold	3,574	–	–	0.04%	28
2023 Q3	$261K	Hold	3,574	–	–	0.04%	31
2023 Q2	$297K	Hold	3,574	–	–	0.04%	32
2023 Q1	$272K	Sell	3,574 -373,854	-99%	-$31M	0.04%	28
2022 Q4	$31.3M	Buy	377,428 +341,878	+962%	+$27.7M	5.51%	8
2022 Q3	$448K	Buy	35,550 +2,482	+8%	+$209K	7.44%	5
2022 Q2	$445K	Buy	+33,068	New	+$2.48M	7.6%	5

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

J. Safra Asset Management's XBI Position: Q2 2025 in Review

J. Safra Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 310,817 shares — an estimated $25.2M sold.

J. Safra Asset Management first reported a position in XBI in Q2 2022 and held it in 12 quarters. The position peaked at $31.3M in Q4 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

J. Safra Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
J. Safra Asset Management sold 310,817 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $25.2M.
J. Safra Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 12 quarters.
J. Safra Asset Management's State Street SPDR S&P Biotech ETF position peaked at $31.3M in Q4 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on J. Safra Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.